Clinical Trial

Jaw Muscle Pain Post Wisdom Molar Surgery

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The proposed design is a triple-blind, placebo-controlled randomized prospective phase II trial to assess the feasibility of employing the Temporo-masseteric Nerve Block (TMNB) injection to decrease jaw muscle pain, overall pain, improve mouth opening and minimize pain medication consumption. 80 participants undergoing lower third molar removal under sedation will be enrolled. Those who develop significant jaw muscle pain on the following day will be randomized to receive either the TMNB injection or a placebo. Daily ecological momentary assessments (EMAs) will be collected reflecting elements of patient experience for all participants. On Day 8, participants return for an end-of-study evaluation and return their unused pain medications. Up to 40 participants who are randomized to receive TMNB/placebo will be recruited to participate in a qualitative interview regarding their experience.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-23; most recent amendment 2026-06-17.
Trial Details
NCT Number NCT07094542
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: National Institute of Dental and Craniofacial Research (NIDCR)
Conditions Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain
Enrollment 80 participants
Start Date 2026-09
Primary Completion 2029-11 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-18